Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Pathogenic Escherichia coli infection WP2272	11/55	1.355198969488816E-11	3.5777252794504744E-9	0	0	24.192401960784313	605.4024662308594	CDC42;TUBB2B;TUBA1A;TUBB2A;TUBB3;ARPC3;TUBB;ARHGEF2;TUBB4B;YWHAZ;TUBB4A
Synaptic Vesicle Pathway WP2267	9/51	3.335109110175863E-9	3.3254138926909887E-7	0	0	20.537101248266296	400.8587594260891	NSF;DNM3;SNAP25;STX1B;STXBP1;CLTC;SYN3;DNM1;VAMP2
Parkin-Ubiquitin Proteasomal System pathway WP2359	10/70	3.778879423512487E-9	3.3254138926909887E-7	0	0	16.036585365853657	311.01094379137874	TUBB2B;PSMC5;TUBA1A;TUBB2A;PSMC6;TUBB3;TUBB;PSMC2;TUBB4B;TUBB4A
Proteasome Degradation WP183	7/62	4.48132639661212E-6	2.4049167037348287E-4	0	0	12.072552447552448	148.68062412149368	UCHL1;PSMA3;PSMC5;PSMC6;PSMB2;PSMC2;HIST1H2AB
Calcium Regulation in the Cardiac Cell WP536	10/150	5.282122286606487E-6	2.4049167037348287E-4	0	0	6.844947735191638	83.17420976838186	CAMK2B;PRKAR1A;PRKAR2B;GNAQ;ATP1B1;YWHAZ;YWHAG;GNAI1;YWHAH;GNAI2
Metabolic reprogramming in colon cancer WP4290	6/42	5.46571978121552E-6	2.4049167037348287E-4	0	0	15.748803827751196	190.8284880797743	ACLY;FASN;ENO1;ACO2;PGD;GAPDH
Regulation of Microtubule Cytoskeleton WP2038	6/46	9.416416686044863E-6	3.5513342930226343E-4	0	0	14.171052631578947	164.00238477736244	CDC42;GSK3B;DPYSL2;MAP1B;GNAQ;MAPT
Fragile X Syndrome  WP4549	8/121	4.977291474336803E-5	0.0015999256540531475	0	0	6.728057800008551	66.66186313070095	CAMK2B;ALDH5A1;PRKAR1A;MAP1B;CLTC;KRAS;GPHN;DNM1
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	9/158	5.454292002453912E-5	0.0015999256540531475	0	0	5.757607349970678	56.51968291958569	SNAP25;PRKAR1A;PRKAR2B;ATP1A3;YWHAZ;GAPDH;YWHAG;VAMP2;YWHAH
Splicing factor NOVA regulated synaptic proteins WP4148	5/42	8.432396856650651E-5	0.002226152770155772	0	0	12.707850707850708	119.21037025980216	CHL1;EPB41L1;NCDN;NEO1;GPHN
Glycolysis in senescence WP5049	3/11	1.8966535013035415E-4	0.004551968403128499	0	0	34.982900943396224	299.81218420581337	ALDOC;ENO1;GAPDH
Lipid Metabolism Pathway WP3965	4/29	2.497783400904498E-4	0.005495123481989896	0	0	14.98388625592417	124.29038760889014	ACLY;PRKAR2B;PRKAR1A;FASN
Myometrial relaxation and contraction pathways WP289	8/156	2.9116326488971264E-4	0.005855743714679721	0	0	5.127823475649563	41.74882298588935	CAMK2B;ACTC1;PRKAR1A;PRKAR2B;GNAQ;YWHAZ;YWHAG;YWHAH
Pathways in clear cell renal cell carcinoma WP4018	6/85	3.105318636572579E-4	0.005855743714679721	0	0	7.161044152383259	57.84135798902519	ACLY;FASN;ALDOC;ENO1;GAPDH;PFKP
Disruption of postsynaptic signaling by CNV WP4875	4/33	4.161113344137118E-4	0.007323559485681329	0	0	12.914528517731656	100.53389244954433	CAMK2B;TJP1;NRXN2;YWHAG
G Protein Signaling Pathways WP35	6/93	5.04097109538106E-4	0.00831760230737875	0	0	6.499917505362151	49.35219423971517	PRKAR1A;PRKAR2B;GNAQ;KRAS;GNAI1;GNAI2
Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380	7/144	9.536214939935139E-4	0.014809180847899275	0	0	4.826501965188097	33.56949749290897	NSF;CDC42;GSK3B;DPYSL2;SIRPA;NCAM1;MAPT
Prolactin Signaling Pathway WP2037	5/76	0.0013631230616610334	0.019037796171548788	0	0	6.610999329309188	43.61922048381245	GSK3B;SIRPA;YWHAZ;PPIA;YWHAG
Glycolysis and Gluconeogenesis WP534	4/45	0.0013701444214372234	0.019037796171548788	0	0	9.12911802103803	60.1868064894923	ALDOC;ENO1;GAPDH;PFKP
Gastrin signaling pathway WP4659	6/114	0.0014643728873575041	0.019329722113119053	0	0	5.2304625199362045	34.13571499789734	CDC42;TJP1;GSK3B;GNAQ;KRAS;RHOB
Fatty Acid Biosynthesis WP357	3/22	0.0016223482903171822	0.0200466070896148	0	0	14.721449851042701	94.5688363583507	ACLY;FASN;ECH1
Metastatic brain tumor WP2249	2/6	0.0016770008542963586	0.0200466070896148	0	0	46.43427230046948	296.74974614939794	CDC42;CDK6
Spinal Cord Injury WP2431	6/118	0.0017464847085649259	0.0200466070896148	0	0	5.042634996582365	32.02148988032123	CDC42;GAP43;PTPRZ1;MIF;RTN4;RHOB
Alzheimer's disease WP2059	5/83	0.002016496708706313	0.022181463795769442	0	0	6.0155677655677655	37.334981135211045	GSK3B;PPP3CB;GNAQ;MAPT;GAPDH
Cardiac Progenitor Differentiation WP2406	4/53	0.0025187412924974955	0.026170904087820662	0	0	7.635554695811974	45.69112867618776	GSK3B;ACTC1;SIRPA;NCAM1
VEGFA-VEGFR2 Signaling Pathway WP3888	12/432	0.00257743752380052	0.026170904087820662	0	0	2.725545390570021	16.246865910555986	CDC42;GSK3B;PTPRZ1;CLTC;RPLP2;MYH9;CCT7;PGD;NDRG1;ACP1;GAPDH;EIF4G2
Amino Acid metabolism WP3925	5/91	0.0030144929571228446	0.029475042247423373	0	0	5.453765227021041	31.655418414416392	ACLY;IDH1;GSS;ACO2;SRM
Corticotropin-releasing hormone signaling pathway WP2355	5/93	0.0033113231460745463	0.031221046805845722	0	0	5.329274891774892	30.43233092492608	GSK3B;PARP1;GNAQ;GNAI1;GNAI2
Pathways Regulating Hippo Signaling WP4540	5/98	0.004144676632958913	0.03773084934831562	0	0	5.04147465437788	27.657179607724824	CDC42;PRKAR1A;PRKAR2B;GNAQ;GNAI2
7q11.23 copy number variation syndrome WP4932	5/104	0.005330536022234706	0.046908716995665414	0	0	4.734487734487734	24.781745619142672	SNAP25;CLTC;GAPDH;VAMP2;CLASP2
The influence of laminopathies on Wnt signaling WP4844	3/35	0.006223569700830858	0.0530007226135273	0	0	8.735112028301886	44.36922962561803	GSK3B;CDK6;EMD
Computational Model of Aerobic Glycolysis WP4629	2/12	0.007071713317772018	0.056573706542176146	0	0	18.568075117370892	91.94265542868631	ENO1;GAPDH
RalA downstream regulated genes WP2290	2/12	0.007071713317772018	0.056573706542176146	0	0	18.568075117370892	91.94265542868631	CDC42;KRAS
Primary focal segmental glomerulosclerosis (FSGS) WP2572	4/72	0.007556374076568018	0.058673022241586964	0	0	5.496793978254809	26.85383844575495	CAMK2B;MYH9;TLN1;DNM1
Cell-type Dependent Selectivity of CCK2R Signaling WP3679	2/13	0.008298653259884334	0.06259555601741326	0	0	16.879214682031584	80.87949217571365	GNAQ;GNAI1
Ferroptosis WP4313	3/40	0.009033491594703935	0.06275899423689049	0	0	7.552779194288628	35.54954437461373	FTH1;GSS;SLC3A2
Glycogen Synthesis and Degradation WP500	3/40	0.009033491594703935	0.06275899423689049	0	0	7.552779194288628	35.54954437461373	GSK3B;PPP2R5E;PPP2R2A
IL-5 signaling pathway WP127	3/40	0.009033491594703935	0.06275899423689049	0	0	7.552779194288628	35.54954437461373	GSK3B;KRAS;MAPT
Cell cycle WP179	5/120	0.00963164485326093	0.06519882669899707	0	0	4.072463768115942	18.907232678296797	GSK3B;CDK6;YWHAZ;YWHAG;YWHAH
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453	2/16	0.012499920116933438	0.08249947277176069	0	0	13.260228034875922	58.10675717236067	ACLY;IDH1
Envelope proteins and their potential roles in EDMD physiopathology WP4535	3/46	0.013243233558398827	0.08440325414880015	0	0	6.49692847740237	28.09446336835875	KRAS;EMD;TMPO
22q11.2 copy number variation syndrome WP4657	5/131	0.013692722240697978	0.08440325414880015	0	0	3.7148526077097506	15.940026917169577	CDC42;HIST1H4A;ACTC1;COMT;RTN4
Airway smooth muscle cell contraction WP4962	2/17	0.014067209024800026	0.08440325414880015	0	0	12.375586854460094	52.76837358358258	GDI1;GNAQ
Cori Cycle WP1946	2/17	0.014067209024800026	0.08440325414880015	0	0	12.375586854460094	52.76837358358258	GAPDH;PFKP
Cytoplasmic Ribosomal Proteins WP477	4/89	0.015584989359734302	0.0914319375771079	0	0	4.393643713409534	18.2839156632753	RPLP1;RPLP2;RPS10;UBA52
Synaptic signaling pathways associated with autism spectrum disorder WP4539	3/50	0.016574156104610556	0.09512124373080841	0	0	5.942794058611	24.364924698932942	CAMK2B;GSK3B;KRAS
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732	2/20	0.019242788347178488	0.10808715156713022	0	0	10.311424100156495	40.736507139702006	GNAQ;KRAS
The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879	3/55	0.02133856767586361	0.11736212221724986	0	0	5.370010885341074	20.6597161386064	GSK3B;EMD;TMPO
Proximal tubule transport WP4917	3/57	0.023432324353107846	0.12624762508613208	0	0	5.17059748427673	19.40855547700152	ATP6V1H;SLC3A2;ATP1B1
Glutathione metabolism WP100	2/23	0.025090238576642023	0.1324764596846699	0	0	8.83702213279678	32.56686919901022	IDH1;GSS
IL-18 signaling pathway WP4754	7/272	0.028086609142186903	0.14538950614779103	0	0	2.478955007256894	8.855973453594961	GSK3B;PARP1;PTPRZ1;NACA;ECH1;HDGF;ENO1
Signal Transduction of S1P Receptor WP26	2/25	0.02933813157086545	0.14625553390798002	0	0	8.067768932435191	28.470085084347566	GNAI1;GNAI2
Insulin Signaling WP481	5/160	0.02951204298364059	0.14625553390798002	0	0	3.0153609831029184	10.62298666745888	CAP1;GSK3B;SNAP25;STXBP1;VAMP2
Endometrial cancer WP4155	3/63	0.030357672801644264	0.14625553390798002	0	0	4.652122641509434	16.25780082814197	GSK3B;KRAS;CTNNA2
EGF/EGFR signaling pathway WP437	5/162	0.030901529128148864	0.14625553390798002	0	0	2.976645435244161	10.349646185046476	CDC42;STXBP1;NEDD8;KRAS;DNM1
DNA damage response (only ATM dependent) WP710	4/110	0.031023901131995758	0.14625553390798002	0	0	3.5194491639095054	12.223037680639658	CDC42;GSK3B;PPP2R5E;KRAS
Chemokine signaling pathway WP3929	5/164	0.032331497357507566	0.14974588249792978	0	0	2.938903863432165	10.085475691619658	CDC42;GSK3B;KRAS;GNAI1;GNAI2
Intracellular trafficking proteins involved in CMT neuropathy WP4856	2/27	0.03384980987183882	0.15039407729108933	0	0	7.421596244131456	25.128203069800627	NEFL;NDRG1
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	3/66	0.03418047211161121	0.15039407729108933	0	0	4.429919137466308	14.955853494672466	GSK3B;NEFL;PFN2
Thyroid stimulating hormone (TSH) signaling pathway WP2032	3/66	0.03418047211161121	0.15039407729108933	0	0	4.429919137466308	14.955853494672466	GNAQ;GNAI1;GNAI2
Nanoparticle-mediated activation of receptor signaling WP2643	2/28	0.036200453498927185	0.156670815142898	0	0	7.135789093535572	23.681426470646194	KRAS;TLN1
Cannabinoid receptor signaling WP3869	2/29	0.03861216037835315	0.16441306999814886	0	0	6.871152842983829	22.360023240601052	PRKAR2B;PRKAR1A
Hippo-Merlin Signaling Dysregulation WP4541	4/120	0.04069074524396774	0.16946885726210736	0	0	3.214414119954241	10.291765201212478	PPP1CC;PRKAR1A;PRKAR2B;KRAS
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844	2/30	0.04108335933626845	0.16946885726210736	0	0	6.62541918175721	21.149345898835282	GSK3B;KRAS
Trans-sulfuration and one-carbon metabolism WP2525	2/31	0.043612505649984624	0.17344649402187992	0	0	6.396632669580702	20.03688473068462	AHCYL2;GSS
Tumor suppressor activity of SMARCB1 WP4204	2/31	0.043612505649984624	0.17344649402187992	0	0	6.396632669580702	20.03688473068462	CDK6;H3F3A
Chromosomal and microsatellite instability in colorectal cancer  WP4216	3/73	0.04401861780100741	0.17344649402187992	0	0	3.9855121293800537	12.447322724915507	GSK3B;DCC;KRAS
miRNA regulation of prostate cancer signaling pathways WP3981	2/33	0.04883859139467004	0.1868606975100419	0	0	5.983340905648947	18.065109116344484	GSK3B;KRAS
Purinergic signaling WP4900	2/33	0.04883859139467004	0.1868606975100419	0	0	5.983340905648947	18.065109116344484	GNAI1;GNAI2
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553	2/35	0.05427857430830015	0.204707765962732	0	0	5.6201451131028595	16.37499929472011	H3F3A;H2AFV
Cellular Proteostasis WP4918	1/6	0.06279858740827005	0.22180998988060052	0	0	18.485981308411215	51.16591868351389	PFDN1
Fluoroacetic acid toxicity WP4966	1/6	0.06279858740827005	0.22180998988060052	0	0	18.485981308411215	51.16591868351389	ACO2
Amyotrophic lateral sclerosis (ALS) WP2447	2/38	0.06281467811869249	0.22180998988060052	0	0	5.151017214397496	14.255782708284048	PPP3CB;NEFL
Striated Muscle Contraction Pathway WP383	2/38	0.06281467811869249	0.22180998988060052	0	0	5.151017214397496	14.255782708284048	ACTC1;TPM1
Focal Adhesion WP306	5/198	0.06301420167062514	0.22180998988060052	0	0	2.4169750801875156	6.681474200583479	CDC42;PPP1CC;GSK3B;TLN1;MYL12A
Acute viral myocarditis WP4298	3/86	0.06556711919238857	0.22544517504226028	0	0	3.359058877017504	9.15236370027429	GSK3B;PARP1;EIF4G2
G13 Signaling Pathway WP524	2/39	0.06575484272065925	0.22544517504226028	0	0	5.011546758025632	13.640538004979394	CDC42;PIP4K2A
Pancreatic adenocarcinoma pathway WP4263	3/89	0.07111360239964494	0.2300017594059643	0	0	3.2413887670030714	8.568535508880402	CDC42;CDK6;KRAS
Glial Cell Differentiation WP2276	1/7	0.07287650558470934	0.2300017594059643	0	0	15.404205607476635	40.34344464999949	GAP43
Mevalonate pathway WP3963	1/7	0.07287650558470934	0.2300017594059643	0	0	15.404205607476635	40.34344464999949	ACAT2
Molybdenum cofactor (Moco) biosynthesis WP4507	1/7	0.07287650558470934	0.2300017594059643	0	0	15.404205607476635	40.34344464999949	GPHN
Pentose Phosphate Metabolism WP134	1/7	0.07287650558470934	0.2300017594059643	0	0	15.404205607476635	40.34344464999949	PGD
Androgen receptor signaling pathway WP138	3/90	0.07300799662651855	0.2300017594059643	0	0	3.2039687703318154	8.385383174557386	CDC42;GSK3B;RHOB
Common Pathways Underlying Drug Addiction WP2636	2/42	0.07484119742825333	0.2300017594059643	0	0	4.634976525821596	12.015651861236954	PPP1CC;GNAI1
Fas ligand pathway and stress induction of heat shock proteins WP314	2/42	0.07484119742825333	0.2300017594059643	0	0	4.634976525821596	12.015651861236954	PARP1;SPTAN1
ErbB signaling pathway WP673	3/91	0.07492481556406412	0.2300017594059643	0	0	3.16739922813036	8.207587001371898	CAMK2B;GSK3B;KRAS
Renin-angiotensin-aldosterone system (RAAS) WP4756	2/44	0.08110759237575375	0.24532680165233484	0	0	4.413816230717639	11.08741237840029	CAMK2B;GNAQ
Integrated breast cancer pathway WP1984	4/152	0.08177560055077827	0.24532680165233484	0	0	2.515306775970283	6.2977656479564175	CDC42;GDI1;KRAS;PHB
HIF1A and PPARG regulation of glycolysis WP2456	1/8	0.08284655391141456	0.2457470812653196	0	0	13.202937249666222	32.88541571880503	GAPDH
Ciliary landscape WP4352	5/216	0.08417806604627684	0.24612892062443936	0	0	2.2087564883773414	5.466276698209461	EFTUD2;PSMC6;GDI1;H3F3A;NEFL
Breast cancer pathway WP4262	4/154	0.08483989309403024	0.24612892062443936	0	0	2.481516587677725	6.1218751409910075	GSK3B;CDK6;PARP1;KRAS
Energy Metabolism WP1541	2/47	0.09079595478538531	0.2576358806359334	0	0	4.118935837245696	9.881905970168374	GSK3B;PPP3CB
NO/cGMP/PKG mediated Neuroprotection WP4008	2/47	0.09079595478538531	0.2576358806359334	0	0	4.118935837245696	9.881905970168374	CAMK2B;NEFL
Cytosine methylation WP3585	1/9	0.09270988128944573	0.2576358806359334	0	0	11.55198598130841	27.473859735815534	IDH1
Methylation Pathways WP704	1/9	0.09270988128944573	0.2576358806359334	0	0	11.55198598130841	27.473859735815534	COMT
Exercise-induced Circadian Regulation WP410	2/48	0.09409771166432329	0.25876870707688904	0	0	4.029189630536845	9.522673605121868	TUBB3;EIF4G2
Wnt signaling pathway and pluripotency WP399	3/102	0.09742503120017974	0.26515678594688097	0	0	2.813893653516295	6.552635664440629	GSK3B;PPP2R5E;PPP2R2A
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518	1/10	0.10246762456232947	0.27324699883287856	0	0	10.26791277258567	23.39244500807539	GSS
Liver X receptor pathway WP2874	1/10	0.10246762456232947	0.27324699883287856	0	0	10.26791277258567	23.39244500807539	FASN
Copper homeostasis WP3286	2/52	0.1076362631076588	0.2785879751021757	0	0	3.7061032863849763	8.260895591254407	GSK3B;MAPT
Wnt Signaling Pathway WP363	2/52	0.1076362631076588	0.2785879751021757	0	0	3.7061032863849763	8.260895591254407	GSK3B;CDK6
One-carbon metabolism and related pathways WP3940	2/52	0.1076362631076588	0.2785879751021757	0	0	3.7061032863849763	8.260895591254407	GSS;DNM1
NAD metabolism, sirtuins and aging WP3630	1/11	0.11212090854714335	0.2873778626839403	0	0	9.240654205607477	20.220191150159177	PARP1
DNA IR-double strand breaks and cellular response via ATM WP3959	2/55	0.11810829981587277	0.299813376455677	0	0	3.4957923642483832	7.467548326427223	PARP1;TP53BP1
Iron metabolism in placenta WP2007	1/12	0.1216708462021688	0.3030292773337034	0	0	8.40016992353441	17.694419176440732	FTH1
Nanoparticle triggered regulated necrosis WP2513	1/12	0.1216708462021688	0.3030292773337034	0	0	8.40016992353441	17.694419176440732	PARP1
Wnt signaling WP428	3/115	0.127048562842655	0.31346561299496184	0	0	2.4856384770889486	5.1283342112650505	CAMK2B;GSK3B;PPP3CB
Dopamine metabolism WP2436	1/13	0.13111853872585816	0.32051198355209776	0	0	7.699766355140187	15.643257181170846	COMT
MET in type 1 papillary renal cell carcinoma WP4205	2/59	0.1324431136146773	0.32077965132362213	0	0	3.2498146775389176	6.569832036834816	CDC42;KRAS
Notch Signaling Pathway Netpath WP61	2/61	0.13975278766182167	0.3340790987776583	0	0	3.139333174186361	6.177831656388722	GSK3B;MAPT
Omega-9 FA synthesis WP4724	1/14	0.1404650756224245	0.3340790987776583	0	0	7.107117181883537	13.949823970578867	FASN
Genotoxicity pathway WP4286	2/63	0.14714761655547143	0.3436856105498224	0	0	3.0360963595782344	5.818129145198848	HIST1H1E;HIST1H2BC
Biogenic Amine Synthesis WP550	1/15	0.14971153489859687	0.3436856105498224	0	0	6.59913217623498	12.532048548494316	COMT
Cysteine and methionine catabolism WP4504	1/15	0.14971153489859687	0.3436856105498224	0	0	6.59913217623498	12.532048548494316	GSS
miRNAs involved in DNA damage response WP1545	1/15	0.14971153489859687	0.3436856105498224	0	0	6.59913217623498	12.532048548494316	CDK6
SREBF and miR33 in cholesterol and lipid homeostasis WP2011	1/16	0.1588589831160387	0.3522187400168195	0	0	6.158878504672897	11.330725094627836	FASN
MAPK pathway in congenital thyroid cancer WP4928	1/16	0.1588589831160387	0.3522187400168195	0	0	6.158878504672897	11.330725094627836	KRAS
NAD+ metabolism WP3644	1/16	0.1588589831160387	0.3522187400168195	0	0	6.158878504672897	11.330725094627836	PARP1
Ebola Virus Pathway on Host WP4217	3/129	0.1620195283542941	0.3522187400168195	0	0	2.2078840970350404	4.018433851756746	CDC42;CLTC;RHOB
Histone Modifications WP2369	2/67	0.1621652478801193	0.3522187400168195	0	0	2.8486818345973277	5.18214940611946	HIST1H4A;H3F3A
Melanoma WP4685	2/68	0.1659623462835603	0.3522187400168195	0	0	2.8053777208706787	5.038442525000758	CDK6;KRAS
Serotonin and anxiety WP3947	1/17	0.16790847553768617	0.3522187400168195	0	0	5.773656542056075	10.302144585073925	CAMK2B
MAP3K1 role in promoting and blocking gonadal determination WP4872	1/17	0.16790847553768617	0.3522187400168195	0	0	5.773656542056075	10.302144585073925	GSK3B
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	1/17	0.16790847553768617	0.3522187400168195	0	0	5.773656542056075	10.302144585073925	GSK3B
Sterol regulatory element-binding proteins (SREBP) signaling WP1982	2/69	0.16977493518530917	0.3522187400168195	0	0	2.763366267255273	4.900226637996051	ACLY;FASN
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	3/132	0.16986161028645214	0.3522187400168195	0	0	2.156208863536639	3.8224650404313416	CAP1;GSK3B;FASN
Circadian rhythm related genes WP3594	4/201	0.17126463932177555	0.3522187400168195	0	0	1.8849568167055597	3.326091730079124	PPP1CC;GSK3B;GNAQ;UBA52
TCA Cycle (aka Krebs or citric acid cycle) WP78	1/18	0.17686105623079498	0.3522187400168195	0	0	5.4337548103353495	9.413387102196012	ACO2
Estrogen metabolism WP697	1/18	0.17686105623079498	0.3522187400168195	0	0	5.4337548103353495	9.413387102196012	COMT
Fatty acid transporters WP5061	1/18	0.17686105623079498	0.3522187400168195	0	0	5.4337548103353495	9.413387102196012	FABP3
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301	1/18	0.17686105623079498	0.3522187400168195	0	0	5.4337548103353495	9.413387102196012	KRAS
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560	1/18	0.17686105623079498	0.3522187400168195	0	0	5.4337548103353495	9.413387102196012	TJP1
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	2/71	0.17744353190241288	0.3522187400168195	0	0	2.682996529904062	4.639176948565197	CAMK2B;KRAS
MECP2 and Associated Rett Syndrome WP3584	2/72	0.1812980496681482	0.3545384082399342	0	0	2.6445338698859824	4.515840200324165	GPRIN1;HNRNPF
Non-small cell lung cancer WP4255	2/72	0.1812980496681482	0.3545384082399342	0	0	2.6445338698859824	4.515840200324165	CDK6;KRAS
Head and Neck Squamous Cell Carcinoma WP4674	2/73	0.18516507725207607	0.3578794756967591	0	0	2.6071546650796797	4.396986006611402	CDK6;KRAS
Nucleotide metabolism WP404	1/19	0.18571775822142422	0.3578794756967591	0	0	5.131619937694704	8.639221676650196	SRM
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	2/74	0.18904390479689204	0.36164920917666304	0	0	2.570813771517997	4.282399856352021	CTNNA2;EMD
Nanomaterial induced apoptosis WP2507	1/20	0.19447960353773455	0.3685406082096298	0	0	4.861288735858338	7.960010231667535	DIABLO
Joubert Syndrome WP4656	2/76	0.19683418847559772	0.3685406082096298	0	0	2.5010785433320644	4.065237026223405	PARP1;MYO5A
Leptin signaling pathway WP2034	2/76	0.19683418847559772	0.3685406082096298	0	0	2.5010785433320644	4.065237026223405	CDC42;GSK3B
Urea cycle and metabolism of amino groups WP497	1/21	0.20314760340500082	0.36912517154464936	0	0	4.617990654205608	7.360257196054018	SRM
FOXA2 pathway WP5066	1/21	0.20314760340500082	0.36912517154464936	0	0	4.617990654205608	7.360257196054018	FASN
Galanin receptor pathway WP4970	1/21	0.20314760340500082	0.36912517154464936	0	0	4.617990654205608	7.360257196054018	VAMP2
Nicotine Activity on Dopaminergic Neurons WP1602	1/21	0.20314760340500082	0.36912517154464936	0	0	4.617990654205608	7.360257196054018	GNAI1
Male infertility WP4673	3/146	0.20777058830194678	0.36912517154464936	0	0	1.9437260852355192	3.0542171277604644	HIST1H4A;PARP1;SIRPA
Methionine De Novo and Salvage Pathway WP3580	1/22	0.21172275831876539	0.36912517154464936	0	0	4.397863818424566	6.827585083249908	SRM
NAD+ biosynthetic pathways WP3645	1/22	0.21172275831876539	0.36912517154464936	0	0	4.397863818424566	6.827585083249908	PARP1
PI3K/AKT/mTOR - VitD3 signaling WP4141	1/22	0.21172275831876539	0.36912517154464936	0	0	4.397863818424566	6.827585083249908	GSK3B
PKC-gamma calcium signaling pathway in ataxia WP4760	1/22	0.21172275831876539	0.36912517154464936	0	0	4.397863818424566	6.827585083249908	GNAQ
Regulation of apoptosis by parathyroid hormone-related protein WP3872	1/22	0.21172275831876539	0.36912517154464936	0	0	4.397863818424566	6.827585083249908	GSK3B
DNA IR-damage and cellular response via ATR WP4016	2/80	0.21252661391964658	0.36912517154464936	0	0	2.372336583604189	3.6740093329901877	PARP1;TP53BP1
Regulation of Actin Cytoskeleton WP51	3/150	0.2189365287558045	0.37301602127235267	0	0	1.8904505198305737	2.8715440804932384	CDC42;PIP4K2A;KRAS
Hippo-Yap signaling pathway WP4537	1/23	0.220206058125105	0.37301602127235267	0	0	4.197748513169074	6.3519975504002195	NDRG1
NRF2-ARE regulation WP4357	1/23	0.220206058125105	0.37301602127235267	0	0	4.197748513169074	6.3519975504002195	GSK3B
Glioblastoma signaling pathways WP2261	2/82	0.22041855802457203	0.37301602127235267	0	0	2.312793427230047	3.497468674601846	CDK6;KRAS
EGFR Tyrosine Kinase Inhibitor Resistance WP4806	2/84	0.22833452277539168	0.379559744016009	0	0	2.2561548150692774	3.3322132346085604	GSK3B;KRAS
MicroRNAs in cardiomyocyte hypertrophy WP1544	2/84	0.22833452277539168	0.379559744016009	0	0	2.2561548150692774	3.3322132346085604	GSK3B;PPP3CB
NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046	1/24	0.22859848219145995	0.379559744016009	0	0	4.015034538805364	5.92534046337219	PARP1
IL-7 signaling pathway WP205	1/25	0.2369009994904709	0.3836924163526645	0	0	3.8475467289719627	5.540901865454593	GSK3B
MTHFR deficiency WP4288	1/25	0.2369009994904709	0.3836924163526645	0	0	3.8475467289719627	5.540901865454593	COMT
Physiological and pathological hypertrophy of the heart WP1528	1/25	0.2369009994904709	0.3836924163526645	0	0	3.8475467289719627	5.540901865454593	PPP3CB
Relationship between inflammation, COX-2 and EGFR WP4483	1/25	0.2369009994904709	0.3836924163526645	0	0	3.8475467289719627	5.540901865454593	KRAS
Retinoblastoma gene in cancer WP2446	2/87	0.24024347312105407	0.38673339575584315	0	0	2.176194421430544	3.103476084071266	CDK6;HMGB2
Wnt/beta-catenin signaling pathway in leukemia WP3658	1/26	0.2451145687595446	0.3921833100152714	0	0	3.6934579439252335	5.193111011399348	GSK3B
Epithelial to mesenchymal transition in colorectal cancer WP4239	3/160	0.24734692629646468	0.3933710153148595	0	0	1.7691383247205865	2.4714214324198682	TJP1;GSK3B;KRAS
1q21.1 copy number variation syndrome WP4905	1/27	0.253240138459512	0.4003317158880908	0	0	3.551222142343638	4.877309132932216	TJP1
TNF-alpha signaling pathway WP231	2/92	0.2601491056331115	0.40880573742346094	0	0	2.054773082942097	2.766752632491569	DIABLO;KRAS
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	2/94	0.268119616584194	0.415654912845789	0	0	2.009899979587671	2.64567569661732	GSK3B;CDK6
T-Cell Receptor and Co-stimulatory Signaling WP2583	1/29	0.26923102309329516	0.415654912845789	0	0	3.297229639519359	4.326576745257571	GSK3B
Gastric Cancer Network 1 WP2361	1/29	0.26923102309329516	0.415654912845789	0	0	3.297229639519359	4.326576745257571	H3F3A
MAPK Signaling Pathway WP382	4/246	0.2727838810358076	0.4171164267245628	0	0	1.530923191414359	1.988784721356687	CDC42;PPP3CB;KRAS;MAPT
Eicosanoid metabolism via cyclooxygenases (COX) WP4719	1/30	0.2770981851649664	0.4171164267245628	0	0	3.1833709313567513	4.085485334604306	AKR1B1
Extracellular vesicle-mediated signaling in recipient cells WP2870	1/30	0.2770981851649664	0.4171164267245628	0	0	3.1833709313567513	4.085485334604306	KRAS
One-carbon metabolism WP241	1/30	0.2770981851649664	0.4171164267245628	0	0	3.1833709313567513	4.085485334604306	AHCYL2
B Cell Receptor Signaling Pathway WP23	2/97	0.2800724018890195	0.4171164267245628	0	0	1.9461329379787498	2.476857268162905	CDC42;GSK3B
Base Excision Repair WP4752	1/31	0.2848810421449348	0.4171164267245628	0	0	3.0771028037383177	3.8638674702576408	PARP1
GABA receptor Signaling WP4159	1/31	0.2848810421449348	0.4171164267245628	0	0	3.0771028037383177	3.8638674702576408	GPHN
Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839	1/32	0.29258049329458025	0.4171164267245628	0	0	2.9776906843533313	3.659627884433879	NCAM1
IL17 signaling pathway WP2112	1/32	0.29258049329458025	0.4171164267245628	0	0	2.9776906843533313	3.659627884433879	GSK3B
Initiation of transcription and translation elongation at the HIV-1 LTR WP3414	1/32	0.29258049329458025	0.4171164267245628	0	0	2.9776906843533313	3.659627884433879	PPP3CB
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817	1/32	0.29258049329458025	0.4171164267245628	0	0	2.9776906843533313	3.659627884433879	TTC9
Monoamine Transport WP727	1/32	0.29258049329458025	0.4171164267245628	0	0	2.9776906843533313	3.659627884433879	AMPH
SARS-CoV-2 mitochondrial interactions WP5038	1/32	0.29258049329458025	0.4171164267245628	0	0	2.9776906843533313	3.659627884433879	PHB
Integrin-mediated Cell Adhesion WP185	2/101	0.29598545353867906	0.4171164267245628	0	0	1.8671219234599516	2.2731181928160518	CDC42;TLN1
Neural Crest Differentiation WP2064	2/101	0.29598545353867906	0.4171164267245628	0	0	1.8671219234599516	2.2731181928160518	GSK3B;RHOB
Endothelin Pathways WP2197	1/33	0.3001974283244959	0.4171164267245628	0	0	2.8844918224299065	3.4709520648936163	GNAI1
MAPK Cascade WP422	1/33	0.3001974283244959	0.4171164267245628	0	0	2.8844918224299065	3.4709520648936163	KRAS
Pregnane X receptor pathway WP2876	1/33	0.3001974283244959	0.4171164267245628	0	0	2.8844918224299065	3.4709520648936163	PSMC5
Prion disease pathway WP3995	1/33	0.3001974283244959	0.4171164267245628	0	0	2.8844918224299065	3.4709520648936163	NCAM1
PI3K-Akt signaling pathway WP4172	5/340	0.3031499121155929	0.4190134910917095	0	0	1.3823738450604122	1.6499016643473172	GSK3B;CDK6;PPP2R5E;PPP2R2A;KRAS
BDNF-TrkB Signaling WP3676	1/34	0.307732727408798	0.4209401038130708	0	0	2.796941376380629	3.2962615342495463	KRAS
p38 MAPK Signaling Pathway WP400	1/34	0.307732727408798	0.4209401038130708	0	0	2.796941376380629	3.2962615342495463	CDC42
Metapathway biotransformation Phase I and II WP702	3/183	0.3143519428646427	0.42671506175579044	0	0	1.5412735849056605	1.7836266547851305	GSS;AKR1B1;COMT
Overview of leukocyte-intrinsic Hippo pathway functions WP4542	1/35	0.3151872615241634	0.42671506175579044	0	0	2.7145409565695435	3.13417732540141	NDRG1
Target Of Rapamycin (TOR) Signaling WP1471	1/36	0.322561892259091	0.4344711201857144	0	0	2.636849132176235	2.9834899708625975	CDC42
Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320	1/37	0.32985747217299294	0.43759986258125694	0	0	2.563473520249221	2.8431346906525783	H3F3A
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850	1/37	0.32985747217299294	0.43759986258125694	0	0	2.563473520249221	2.8431346906525783	GSK3B
Melatonin metabolism and effects WP3298	1/37	0.32985747217299294	0.43759986258125694	0	0	2.563473520249221	2.8431346906525783	GSK3B
Parkinson's disease pathway WP2371	1/38	0.33707484466493093	0.4449387949577088	0	0	2.4940641576155596	2.712170772259557	UCHL1
Kisspeptin/kisspeptin receptor system in the ovary WP4871	1/39	0.34421484426472787	0.45210307903426944	0	0	2.4283079193310377	2.5897643384645814	KRAS
ATM Signaling Pathway WP2516	1/40	0.35127829655782955	0.45237790385983906	0	0	2.365923795830338	2.4751738806817505	TP53BP1
Bladder cancer WP2828	1/40	0.35127829655782955	0.45237790385983906	0	0	2.365923795830338	2.4751738806817505	KRAS
Oxidative Damage WP3941	1/40	0.35127829655782955	0.45237790385983906	0	0	2.365923795830338	2.4751738806817505	CDC42
PDGF Pathway WP2526	1/40	0.35127829655782955	0.45237790385983906	0	0	2.365923795830338	2.4751738806817505	CDC42
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	1/41	0.35826601847217937	0.45913703338182216	0	0	2.306658878504673	2.3677380526517173	SUGT1
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	1/42	0.3651788181429163	0.46127850712789426	0	0	2.2502849327558696	2.2668653306348214	GSK3B
DNA Replication WP466	1/42	0.3651788181429163	0.46127850712789426	0	0	2.2502849327558696	2.2668653306348214	UBA52
IL-2 signaling pathway WP49	1/42	0.3651788181429163	0.46127850712789426	0	0	2.2502849327558696	2.2668653306348214	MAPT
DNA Repair Pathways Full Network WP4946	2/120	0.37048405995836636	0.465462647943647	0	0	1.5649717514124293	1.5539306538336832	PARP1;RAD23A
IL-6 signaling pathway WP364	1/43	0.37201749513677845	0.465462647943647	0	0	2.196595460614152	2.1720252133739733	GSK3B
Nucleotide Excision Repair WP4753	1/44	0.37878284066719875	0.4716918393214173	0	0	2.145403173223212	2.0827407047914677	RAD23A
ATM Signaling Network in Development and Disease  WP3878	1/45	0.3854756372944551	0.4733282243987728	0	0	2.0965378079864063	1.9985818708715468	TP53BP1
Nephrotic syndrome WP4758	1/45	0.3854756372944551	0.4733282243987728	0	0	2.0965378079864063	1.9985818708715468	MYH9
Prostaglandin Synthesis and Regulation WP98	1/45	0.3854756372944551	0.4733282243987728	0	0	2.0965378079864063	1.9985818708715468	AKR1B1
Aryl Hydrocarbon Receptor Netpath WP2586	1/46	0.39209665951706524	0.476421841462633	0	0	2.0498442367601246	1.919160289984461	KRAS
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718	1/46	0.39209665951706524	0.476421841462633	0	0	2.0498442367601246	1.919160289984461	FASN
mRNA Processing WP411	2/126	0.3934089448441439	0.476421841462633	0	0	1.48879297289111	1.3889033552625902	EFTUD2;SNRPA1
Endoplasmic reticulum stress response in coronavirus infection WP4861	1/47	0.3986466734241839	0.4783760081090207	0	0	2.005180820804551	1.8441242655039944	PPP1CC
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534	1/47	0.3986466734241839	0.4783760081090207	0	0	2.005180820804551	1.8441242655039944	ACTC1
Rett syndrome causing genes WP4312	1/48	0.4051264370854153	0.4839519429436635	0	0	1.9624179757407039	1.7731546743727635	STXBP1
Hepatitis C and Hepatocellular Carcinoma WP3646	1/49	0.411536700451846	0.48720039874119886	0	0	1.9214369158878504	1.7059613615486515	UCHL1
Phosphoinositides metabolism WP4971	1/49	0.411536700451846	0.48720039874119886	0	0	1.9214369158878504	1.7059613615486515	PIP4K2A
Translation Factors WP107	1/52	0.430357869259717	0.5049532332647346	0	0	1.8081363386476086	1.5245087498158911	EEF1A2
Netrin-UNC5B signaling pathway WP4747	1/52	0.430357869259717	0.5049532332647346	0	0	1.8081363386476086	1.5245087498158911	NEO1
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	1/53	0.43649747296771096	0.5094723595522146	0	0	1.773274622573688	1.469996239349117	SERBP1
Ectoderm Differentiation WP2858	2/138	0.43806903643315426	0.5094723595522146	0	0	1.3566003866335266	1.1197091498171254	HMGB2;CTNNA2
Cardiac Hypertrophic Response WP2795	1/55	0.4485797786033474	0.5156787977875673	0	0	1.7074247144340602	1.3687890102238875	GSK3B
RANKL/RANK signaling pathway WP2018	1/55	0.4485797786033474	0.5156787977875673	0	0	1.7074247144340602	1.3687890102238875	CDC42
Nuclear Receptors Meta-Pathway WP2882	4/319	0.44926561928462305	0.5156787977875673	0	0	1.1717445271947642	0.9375608218636629	PSMC5;FTH1;FASN;PGD
Complement and Coagulation Cascades WP558	1/58	0.46622142223644886	0.5312290874726927	0	0	1.6173143138219381	1.2341638237357344	CLTC
NRF2 pathway WP2884	2/146	0.4668376829305481	0.5312290874726927	0	0	1.2807120500782472	0.9756127003583726	FTH1;PGD
Kit receptor signaling pathway WP304	1/59	0.47197621840980963	0.5347713375973809	0	0	1.589349017080245	1.1933256448875735	MAPT
Prader-Willi and Angelman Syndrome WP3998	1/61	0.48330119480753325	0.5452628864495247	0	0	1.536214953271028	1.1170052859249018	CDK6
Hepatitis B infection WP4666	2/152	0.4878359638037988	0.5468745317359033	0	0	1.2291079812206573	0.8822242956077536	KRAS;YWHAZ
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	1/62	0.48887268746088325	0.5468745317359033	0	0	1.5109544967059905	1.0813193847303337	GSK3B
Nonalcoholic fatty liver disease WP4396	2/155	0.49814096933678514	0.5544409426153165	0	0	1.2048237135229678	0.8396081169838383	CDC42;GSK3B
G1 to S cell cycle control WP45	1/64	0.49983691038805045	0.5544409426153165	0	0	1.4628393413440142	1.014440190700595	CDK6
Oncostatin M Signaling Pathway WP2374	1/65	0.505230911728173	0.5557540029009904	0	0	1.4399094626168225	0.9830833592387263	KRAS
Pathways affected in adenoid cystic carcinoma WP3651	1/65	0.505230911728173	0.5557540029009904	0	0	1.4399094626168225	0.9830833592387263	HIST1H1E
AGE/RAGE pathway WP2324	1/66	0.5105670089696963	0.5592933210290449	0	0	1.4176851186196981	0.9530152711759711	CDC42
PPAR signaling pathway WP3942	1/67	0.5158458208903408	0.5627408955167353	0	0	1.3961342395921834	0.9241673669461691	FABP3
DNA damage response WP707	1/68	0.5210679595951159	0.5637784480865189	0	0	1.3752266703863858	0.8964756176629279	CDK6
RAC1/PAK1/p38/MMP2 Pathway WP3303	1/68	0.5210679595951159	0.5637784480865189	0	0	1.3752266703863858	0.8964756176629279	KRAS
AMP-activated protein kinase (AMPK) signaling WP1403	1/69	0.5262340308411215	0.5670440169063514	0	0	1.354934029686641	0.8698801661628217	FASN
miRNA regulation of DNA damage response WP1530	1/71	0.5364003608292154	0.575649167719158	0	0	1.3160881174899866	0.8197576687661631	CDK6
16p11.2 proximal deletion syndrome WP4949	1/74	0.5512441231286235	0.5891840020484074	0	0	1.2618102675713736	0.7515058213775376	CCT7
Ras signaling WP4223	2/184	0.5906817919324543	0.6287902946377739	0	0	1.0113501521952226	0.532453433198506	CDC42;KRAS
Apoptosis WP254	1/84	0.5973896776194018	0.6333770075964742	0	0	1.1092219344668393	0.5714552257340338	DIABLO
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	1/86	0.6060355771307744	0.6399735694500978	0	0	1.0830126443100605	0.542390695659147	GSK3B
Apoptosis Modulation and Signaling WP1772	1/90	0.6227768400284975	0.6524328800298546	0	0	1.034127900871574	0.48972887510455126	DIABLO
T-cell receptor (TCR) signaling pathway WP69	1/90	0.6227768400284975	0.6524328800298546	0	0	1.034127900871574	0.48972887510455126	CDC42
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	3/303	0.6352550449417004	0.662874829504383	0	0	0.9191037735849057	0.4170237742781574	GSK3B;PPP2R5E;KRAS
Thyroid hormones production and their peripheral downstream signaling effects WP4746	1/95	0.642710974140098	0.6680145557991569	0	0	0.9788725392722211	0.43272054319798114	GSK3B
Small cell lung cancer WP4658	1/96	0.6465701480274958	0.6693902708990546	0	0	0.9685194294146582	0.42234573717029367	CDK6
Complement system WP2806	1/97	0.6503878294810889	0.6707124491523729	0	0	0.9583820093457944	0.4122829383236027	GNAI2
Electron Transport Chain (OXPHOS system in mitochondria) WP111	1/103	0.6724471167821808	0.6907627970058199	0	0	0.9017317207256734	0.3578358284833666	SLC25A5
Senescence and Autophagy in Cancer WP615	1/105	0.6794878606943988	0.6952899039663616	0	0	0.8843008626887131	0.34170792310605486	GSK3B
Thermogenesis WP4321	1/108	0.6897675081603285	0.7030834832213386	0	0	0.8593763647480129	0.3191729687051323	KRAS
ESC Pluripotency Pathways WP3931	1/116	0.7156034920880915	0.7266127765817544	0	0	0.7992685900040634	0.26745848690198903	GSK3B
Adipogenesis WP236	1/130	0.7557681759140695	0.7644551664418175	0	0	0.7120191262768963	0.19938001970778307	MIF
TGF-beta Signaling Pathway WP366	1/132	0.7610250194325272	0.7668343707259052	0	0	0.7010772633231076	0.1914565200416486	CDC42
Mesodermal commitment pathway WP2857	1/147	0.797022287051391	0.8000527900439818	0	0	0.628568685187556	0.14260503508432607	PRKAR1A
Vitamin D Receptor Pathway WP2877	1/182	0.8613894420493053	0.8613894420493053	0	0	0.5061186554448288	0.0755172373730993	TPM1
